Abstract
Due to the increased rate of infectious diseases, an insufficient number of therapeutics and antibiotic resistance, the detection of potential sources of novel therapeutic agents is of crucial importance. As the current medicines are simply not sufficient, further studies have been based on a combinational approach that evaluates the synergistic pharmacological activity of plantderived compounds and other medicines. Curcumin, a natural polyphenol extracted from plant Curcuma longa L., and rosuvastatin, synthetic lipid-lowering medicine, pose a wide range of pharmacological properties. So far, the combined activity of curcumin and rosuvastatin has not been investigated. The aim of this study was to examine the potential synergistic antimicrobial, antioxidant and anti-inflammatory in vitro activity of a combination of curcumin and rosuvastatin. In vitro agar well diffusion method was used to determine antibacterial activity against Gram-positive and Gram-negative bacteria as well as the antifungal activity. Antioxidant activity was evaluated by a commonly used in vitro assay for scavenging free radicals. In vitro assay of inhibition of protein denaturation was applied for the determination of anti-inflammatory activity. Results have demonstrated that a combination of curcumin and rosuvastatin suppressed the growth of all tested strains of microorganisms, therefore implying significant antimicrobial activity. Results have also suggested that a combination of curcumin and rosuvastatin shows a dose-dependent activity in scavenging free radicals and inhibiting protein denaturation. Therefore, the present in vitro study emphasizes the potential application of a combination of curcumin and rosuvastatin as antimicrobial, antioxidant and anti-inflammatory agents. However, current findings are limited to in vitro assays and further research should be conducted involving in vivo models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carvalho, C., Varela, S.A.M., Bastos, L.F., et al.: The relevance of in silico, in vitro and non-human primate based approaches to clinical research on major depressive disorder. Altern Lab Anim. 47(3–4), 128–139 (2019)
Pehlivanović, B.: In vitro models to determine the pharmacokinetic parameters. Folia Med. Fac. Med. Univ. Saraeviensis 50(1), 40–42 (2015)
Haddadi, M., Javad, M.M., Mohseni, S., Golnaz, M.: In vitro ADME screening instead of in vivo studies in preclinical safety. Biomed. J. Sci. Tech. Res. 24(4), 1837118376 (2020)
Freedman, D.H.: Hunting for New Drugs with AI. The pharmaceutical industry is in a drug-discovery slump. How much can AI help? Nature 576, S49–S53 (2019)
Bałan, B.J., et al.: Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells. In: Pokorski, M. (ed.) Clinical Research and Practice. AEMB, vol. 1020, pp. 91–104. Springer, Cham (2017). https://doi.org/10.1007/5584_2017_17
Aggarwal, B.B., Sung, B.: Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30(2), 85–94 (2009)
Pulido-Moran, M., Moreno-Fernandez, J., Ramirez-Tortosa, C., Ramirez-Tortosa, M.: Curcumin and Health. Molecules 21(3), 264 (2016)
Alisi, I.O., Uzairu, A., Abechi, S.E., Idris, S.: Evaluation of the antioxidant properties of curcumin derivatives by genetic function algorithm. J. Adv. Res. 12, 4754 (2018)
McTaggart, F.: Comparative pharmacology of rosuvastatin. Atherosclerosis 4(1), 9–14 (2003)
Fabijanić, D.: Pleiotropic effects of statins. Medicus 19(2), 163–169 (2010)
Beevers, C.S., Huang, S.: Pharmacological and clinical properties of curcumin. Botanics Targets Therapy 1, 5–18 (2011)
Collins, R., Reith, C., Emberson, J.: Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388(10059), 2532–2561 (2016)
Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T.P., Sahebkar, A.: Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. J. Cell Physiol. 233(1), 141–152 (2018)
Pehlivanović, B., Bečić, F.: Curcumin: phytochemical therapy in the treatment of hyperlipidemia. Bull. Chemists Technol. Bosnia and Herzegovina 52, 1116 (2019)
Zhao, J.F., Ching, L.C., Huang, Y.C., Chen, C.Y., Chiang, A.N., Kou, Y.R., et al.: Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol. Nutr. Food Res. 56(5), 691–701 (2012)
Pehlivanović, B., Čaklovica, K., Lagumdžija, D., Žiga Smajić, N., Bečić, F.: In vitro evaluation of pleiotropic properties of rosuvastatin. Int. J. Pharm. Sci. Res. 12(2), 1000–1006 (2021)
Oesterle, A., Laufs, U., Liao, J.K.: Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 120, 229–243 (2017)
Banfi, C., Baetta, R., Gianazza, E., Tremoli, E.: Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins. Drug Discov. Today. 22, 848–869 (2017)
Jeenger, M.K., Shrivastava, S., Yerra, V.G., Naidu, V.G., Ramakrishna, S., Kumar, A.: Curcumin: a pleiotropic phytonutrient in diabetic complications. Nutrition. 31(2), 276–282 (2015)
Ullah, A.H.M., et al.: Evaluation of antinociceptive, in-vivo & in-vitro anti-inflammatory activity of ethanolic extract of Curcuma zedoaria rhizome. Complement. Alternat. Med. 14, 346–354 (2014)
Pehlivanović, B., et al.: Curcumin: natural antimicrobial and anti-inflammatory agent. J. Pharm. Res. Int. 32(43), 1–8 (2020)
Umeda, R., Takanari, H., Ogata, K., et al.: Direct free radical scavenging effects of watersoluble HMG-CoA reductase inhibitors. J. Clin. Biochem. Nutr. 64(1), 20–26 (2019)
Rajkiran, M., Deepa, K.: Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. Eur. J. Pharmacol. 711(1–3), 57–62 (2013)
Sökmen, M., Akram Khan, M.: The antioxidant activity of some curcuminoids and chalcones. Inflammopharmacology 24(2–3), 81–86 (2016). https://doi.org/10.1007/s10787-016-0264-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Pehlivanović, B. et al. (2021). Potentially New Synergistic Combination of Curcumin and Rosuvastatin: An in Vitro Study. In: Badnjevic, A., Gurbeta Pokvić, L. (eds) CMBEBIH 2021. CMBEBIH 2021. IFMBE Proceedings, vol 84. Springer, Cham. https://doi.org/10.1007/978-3-030-73909-6_49
Download citation
DOI: https://doi.org/10.1007/978-3-030-73909-6_49
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-73908-9
Online ISBN: 978-3-030-73909-6
eBook Packages: EngineeringEngineering (R0)